These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 37376587)

  • 1. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.
    Akkiz H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and liver injury: An ongoing challenge.
    Papagiouvanni I; Kotoulas SC; Pataka A; Spyratos DG; Porpodis K; Boutou AK; Papagiouvannis G; Grigoriou I; Vettas C; Goulis I
    World J Gastroenterol; 2023 Jan; 29(2):257-271. PubMed ID: 36687117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.
    Rodriguez-Espada A; Salgado-de la Mora M; Rodriguez-Paniagua BM; Limon-de la Rosa N; Martinez-Gutierrez MI; Pastrana-Brandes S; Navarro-Alvarez N
    World J Gastroenterol; 2024 Jun; 30(22):2866-2880. PubMed ID: 38947288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.
    Li P; Liu Y; Cheng Z; Yu X; Li Y
    Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups.
    Liatsos GD
    World J Gastroenterol; 2023 Apr; 29(16):2397-2432. PubMed ID: 37179584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection and liver involvement.
    Luo M; Ballester MP; Soffientini U; Jalan R; Mehta G
    Hepatol Int; 2022 Aug; 16(4):755-774. PubMed ID: 35767172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune sclerosing cholangitis might be triggered by SARS-CoV-2 infection in a child - a case report.
    Zdanowicz K; Bobrus-Chociej A; Kopiczko A; Uścinowicz M; Tomczuk-Ostapczuk M; Janica J; Łotowska JM; Białokoz-Kalinowska I; Lebensztejn DM
    Cent Eur J Immunol; 2022; 47(2):183-187. PubMed ID: 36751389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of COVID-19 on Liver Injury.
    Dawood DRM; Salum GM; El-Meguid MA
    Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
    Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.
    Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM
    Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
    Saviano A; Wrensch F; Ghany MG; Baumert TF
    Hepatology; 2021 Aug; 74(2):1088-1100. PubMed ID: 33332624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver injury in the era of COVID-19.
    Cichoż-Lach H; Michalak A
    World J Gastroenterol; 2021 Feb; 27(5):377-390. PubMed ID: 33584070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.